In silico study of Actinium-225 (225AC) labelled pentixafor targeting CXCR4 and genetic dependency for breast cancer therapy
Conference proceeding in AIP Conference Proceedings (February 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Conference proceeding in AIP Conference Proceedings (February 2024)
Book chapter (November 2023)
Article in Current Radiopharmaceuticals (October 2023)